Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Arm Holdings To Join the Nasdaq-100 Index
01:20pm, Friday, 14'th Jun 2024
Arm Holdings (ARM) could get a boost after the Nasdaq announced that the British semiconductor and software design company would be added to the Nasdaq-100 Index.
Tempus AI shares soar in Nasdaq debut
12:32pm, Friday, 14'th Jun 2024
SoftBank Group-backed Tempus AI shares surged over 15% after its Nasdaq debut Friday, valuing the AI-driven genetic testing company at around $6.6 billion. The stock opened at $40 per share and rose t
Tempus AI shares jump 8% in Nasdaq debut
12:16pm, Friday, 14'th Jun 2024
Shares of SoftBank Group-backed Tempus AI rose 8.1% in their debut on the Nasdaq on Friday, giving the artificial intelligence-based genetic testing company a valuation of $6.6 billion.
Super Micro Could Be Next to Join Nasdaq 100. Walgreens Could Be Dropped.
11:10am, Friday, 14'th Jun 2024
On Thursday evening, the index added Arm Holdings, the U.K. chip maker, and dropped Sirius XM Holdings in a move that Barron's had predicted could happen.
Nasdaq Index, Dow Jones, S&P 500 News: Futures Dip in Premarket; Adobe Surges
08:42am, Friday, 14'th Jun 2024
The S&P 500's 21x earnings valuation suggests a potentially overextended market, but excluding top performers shows a more reasonable valuation.
Arm Holdings promoted into Nasdaq 100
07:51am, Friday, 14'th Jun 2024
Arm Holdings PLC's (NASDAQ:ARM) elevation to ‘tech royalty' was confirmed yesterday with the UK-based but US-listed chip designer being added to the Nasdaq 100 and a clutch of other indices. The Br
Arm Holdings to Replace Sirius XM in Nasdaq 100 Index
10:55pm, Thursday, 13'th Jun 2024
The change, which comes as Sirius' market value falls below 0.1% of the index's capitalization, will take place before the start of trading on June 24.
Arm Holdings plc to Join the Nasdaq-100 Index® Beginning June 24, 2024
08:00pm, Thursday, 13'th Jun 2024
NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Arm Holdings plc (Nasdaq: ARM), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®), the Nasdaq-100
Atlantic Coastal Acquisition Corp. II Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
04:15pm, Thursday, 13'th Jun 2024
NEW YORK, June 13, 2024 /PRNewswire/ -- Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) (the "Company"), a special purpose acquisition company, announced that it had previously received written n
Nasdaq 100, Dow Jones, S&P 500 News: Mixed After Positive PPI Data; Broadcom Shares Surge
10:34am, Thursday, 13'th Jun 2024
Given the encouraging inflation data and the Fed's cautious optimism, the S&P 500 is likely to maintain its upward momentum in the near term.
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
08:30am, Thursday, 13'th Jun 2024
TORONTO , June 13, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting e
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Thursday, 13'th Jun 2024
EMERYVILLE, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccines, today announced
Is It Time to Buy May's Worst-Performing Nasdaq Stocks?
06:45am, Thursday, 13'th Jun 2024
Software businesses like MongDB were a drag on the market in May. Medical testing company Exact Sciences also took a sharp turn lower.
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06:03pm, Wednesday, 12'th Jun 2024
SAN DIEGO, CA and TAICANG, China, June 12, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect or the Company), a U.S.-headquartered, global clinical-stage biopharmaceu
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Wednesday, 12'th Jun 2024
SOUTH SAN FRANCISCO, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on June 10, 2024, it granted stock options to purchase an aggregate of 120
